Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases
Purchaser
Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency
Country
Belgium
Notice published
2 Jul 2026
Tenqual indexed
2 Jul 2026
Closing date
2 Sept 2026
Source ID
Docs found
—
Save this notice and create a free tender alert for similar public opportunities.
- Create one free tender alert.
- See a short explanation of why each tender matches.
- Upgrade later when you want help planning and writing the bid.
Tender summary
This call for tenders aims at speeding up the development of promising Next Generation Therapeutics for Infectious Diseases by adopting a competitive development in phases, under Pre-Commercial Procurement (PCP). The scope of the call is expected to cover the development of innovative therapeutics to treat viral infections, ARDS or sepsis resulting from infections, including pathogen-targeted therapeutics (but not small molecules or monoclonal antibodies) and host-targeted therapeutics, among which but not only direct-acting antivirals, indirect-acting antivirals and novel immune modulators. It may also cover innovative combinations therapies and products designed to be administered through alternative routes to IV. Broad spectrum therapeutics, pathogen-agnostic therapeutics and therapeutics that could reduce or counteract the emergence of viral resistance are of particular interest.
What to check before bidding
- Issued by Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency.
- Located in Belgium.
- Source notice 456593-2026 on TED.
- Notice published 2 Jul 2026; Tenqual indexed it 2 Jul 2026.
- Deadline listed as 2 Sept 2026.
- Create a free tender alert to catch similar opportunities before the deadline pressure starts.